KPTI — Karyopharm Therapeutics Share News
0.000.00%
Last trade - 00:00- $11.74m
- $268.91m
- $146.07m
Karyopharm Therapeutics Q2 revenue falls 11%
Karyopharm Therapeutics Inc expected to post a loss of $4.10 a share - Earnings Preview
Karyopharm Therapeutics Inc expected to post a loss of $4.10 a share - Earnings Preview
U.S. STOCKS ON THE MOVE-AeroVironment, Civista Bancshares, Meta
U.S. STOCKS ON THE MOVE-RTX, Performance Food, MiNK Therapeutics
U.S. STOCKS ON THE MOVE-Cloudfare, Karyopharm, AMC Entertainment
Karyopharm Therapeutics to cut workforce by 20%; shares fall
Brief: Karyopharm Therapeutics Inc Reducing Workforce By About 20%
Brief: Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule
Karyopharm Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: Karyopharm Therapeutics Q1 Net Income USD -23.462 Million
Karyopharm Therapeutics Inc expected to post a loss of $4.18 a share - Earnings Preview
Karyopharm Therapeutics Inc expected to post a loss of $4.18 a share - Earnings Preview
Brief: Karyopharm Therapeutics Q4 Net Income USD -30.78 Million
Karyopharm Therapeutics Inc expected to post a loss of 26 cents a share - Earnings Preview
Brief: Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Karyopharm Therapeutics Provides Endometrial Cancer Program Update